Related Experiment Videos
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
Bradford J Shingleton1, Iftikhar M Chaudhry, Mark W O'Donoghue
1Ophthalmic Consultants of Boston, Center for Eye Research and Education, Boston, Massachusetts 02114, USA.
Journal of Cataract and Refractive Surgery
|May 31, 2002
Summary
Peripheral iridectomy (PI) during phacotrabeculectomy did not significantly impact intraocular pressure or visual acuity. However, PI may reduce the need for additional therapies for bleb development in glaucoma patients.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Glaucoma and cataracts frequently coexist, requiring combined surgical intervention.
- Phacotrabeculectomy is a standard procedure for managing combined cataract and glaucoma.
- The role of peripheral iridectomy (PI) in phacotrabeculectomy is debated.
Purpose of the Study:
- To evaluate the impact of peripheral iridectomy (PI) on outcomes following phacotrabeculectomy.
- To compare intraocular pressure (IOP), bleb development, visual acuity, and complications between phacotrabeculectomy with and without PI.
Main Methods:
- Retrospective analysis of 126 eyes from 117 patients undergoing phacotrabeculectomy.
- Patients were randomized to receive either peripheral iridectomy (PI) or no PI.
- Key postoperative parameters including IOP, bleb formation, visual acuity, and complications were assessed over 12 months.
Main Results:
- No statistically significant differences were observed in visual acuity or intraocular pressure (IOP) between the PI and no-PI groups.
- The group without PI required significantly more 5-fluorouracil therapy for bleb development compared to the PI group.
- Bleb failure rates and the need for laser suture lysis were not significantly different between the two groups. Complications were infrequent in both groups.
Conclusions:
- Phacotrabeculectomy performed without a peripheral iridectomy (PI) appears to be a viable alternative for managing patients with concurrent cataracts and glaucoma.
- The addition of PI may reduce the need for adjunctive therapies for bleb management, though overall efficacy and safety remain comparable.